Literature DB >> 26437064

Influence of melphalan plus fludarabine-conditioning regimen in elderly patients aged ⩾55 years with hematological malignancies.

K Miyao1, M Sawa1, Y Kuwatsuka2, Y Ozawa3, T Kato1, A Kohno4, H Sao5, T Nishida6, H Iida7, K Naito8, H Tsurumi9, H Taji10, S Mizuta11, S Kusumoto12, K Nakase13, Y Morishita4, N Kawashima3, K Miyamura3, M Murata6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26437064     DOI： 10.1038/bmt.2015.235

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  15 in total

1.  Tacrolimus clearance is age-dependent within the pediatric population.

Authors:  D Przepiorka; D Blamble; S Hilsenbeck; M Danielson; R Krance; K W Chan
Journal:  Bone Marrow Transplant       Date:  2000-09       Impact factor: 5.483

2.  Chronic graft-versus-host disease after allogeneic blood stem cell transplantation.

Authors:  D Przepiorka; P Anderlini; R Saliba; K Cleary; R Mehra; I Khouri; Y O Huh; S Giralt; I Braunschweig; K van Besien; R Champlin
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

3.  Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System.

Authors:  Yoshiko Atsuta; Ritsuro Suzuki; Ayami Yoshimi; Hisashi Gondo; Junji Tanaka; Akira Hiraoka; Koji Kato; Ken Tabuchi; Masahiro Tsuchida; Yasuo Morishima; Makoto Mitamura; Keisei Kawa; Shunichi Kato; Tokiko Nagamura; Minoko Takanashi; Yoshihisa Kodera
Journal:  Int J Hematol       Date:  2007-10       Impact factor: 2.490

4.  Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years.

Authors:  Raymond Wong; Sergio A Giralt; Thomas Martin; Daniel R Couriel; Athanasios Anagnostopoulos; Chitra Hosing; Borje S Andersson; Pedro Cano; Munir Shahjahan; Cindy Ippoliti; Elihu H Estey; John McMannis; James L Gajewski; Richard E Champlin; Marcos de Lima
Journal:  Blood       Date:  2003-07-03       Impact factor: 22.113

5.  Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation.

Authors:  Philippe Armand; Haesook T Kim; Brent R Logan; Zhiwei Wang; Edwin P Alyea; Matt E Kalaycio; Richard T Maziarz; Joseph H Antin; Robert J Soiffer; Daniel J Weisdorf; J Douglas Rizzo; Mary M Horowitz; Wael Saber
Journal:  Blood       Date:  2014-04-17       Impact factor: 22.113

6.  A randomized phase II trial of fludarabine/melphalan 100 versus fludarabine/melphalan 140 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma.

Authors:  Qaiser Bashir; Hassan Khan; Peter F Thall; Ping Liu; Nina Shah; Partow Kebriaei; Simrit Parmar; Betul Oran; Stefan Ciurea; Yago Nieto; Roy Jones; Chitra M Hosing; Uday R Popat; Yvonne T Dinh; Gabriela Rondon; Robert Z Orlowski; Jatin J Shah; Marcos De Lima; Elizabeth Shpall; Richard Champlin; Sergio Giralt; Muzaffar H Qazilbash
Journal:  Biol Blood Marrow Transplant       Date:  2013-07-17       Impact factor: 5.742

7.  Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research.

Authors:  Sergio Giralt; Karen Ballen; Douglas Rizzo; Andreas Bacigalupo; Mary Horowitz; Marcelo Pasquini; Brenda Sandmaier
Journal:  Biol Blood Marrow Transplant       Date:  2009-03       Impact factor: 5.742

Review 8.  1994 Consensus Conference on Acute GVHD Grading.

Authors:  D Przepiorka; D Weisdorf; P Martin; H G Klingemann; P Beatty; J Hows; E D Thomas
Journal:  Bone Marrow Transplant       Date:  1995-06       Impact factor: 5.483

9.  Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience.

Authors:  Paolo Anderlini; Rima Saliba; Sandra Acholonu; Sergio A Giralt; Borje Andersson; Naoto T Ueno; Chitra Hosing; Issa F Khouri; Daniel Couriel; Marcos de Lima; Muzaffar H Qazilbash; Barbara Pro; Jorge Romaguera; Luis Fayad; Frederick Hagemeister; Anas Younes; Mark F Munsell; Richard E Champlin
Journal:  Haematologica       Date:  2008-01-26       Impact factor: 9.941

Review 10.  Risk assessment in haematopoietic stem cell transplantation: impact of donor-recipient sex combination in allogeneic transplantation.

Authors:  Gösta Gahrton
Journal:  Best Pract Res Clin Haematol       Date:  2007-06       Impact factor: 3.020
View more
  1 in total

1.  Curative potential of fludarabine, melphalan, and non-myeloablative dosage of busulfan in elderly patients with myeloid malignancy.

Authors:  Tomoaki Ueda; Tomoyasu Jo; Kazuya Okada; Yasuyuki Arai; Takayuki Sato; Takeshi Maeda; Tatsuhito Onishi; Yasunori Ueda
Journal:  Int J Hematol       Date:  2019-11-07       Impact factor: 2.490
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.